Skip to main content

Living with Rosacea

Even though living with rosacea may feel challenging, remember that you are not alone. Rosacea affects an estimated 16 million Americans.

Living with rosacea often goes beyond the physical symptoms.

For some, the physical symptoms of rosacea can have a significant emotional impact. In a survey conducted by the National Rosacea Society of more than 1,200 rosacea patients:

77% of patients surveyed said rosacea lowered their self-confidence

42% said it caused them to avoid public or social engagements

Picture of woman and man with Rosacea Picture of woman with Rosacea Picture of man with Rosacea

Healthy Skin Care Tips That Can Help Keep Flare-ups at Bay

Being aware of your triggers and incorporating a gentle skin care routine can help manage your rosacea symptoms. Ask your dermatologist to recommend a skin care routine that is easy on sensitive skin.

  • 1

    Find a dermatologist.

    Rosacea is a chronic and progressive vascular and inflammatory skin condition which needs to be diagnosed by a doctor or dermatologist. The good news is that once you know what it is, you can learn how to treat it. Find a dermatologist near you.

  • 2

    Moisturize, moisturize, moisturize.

    Did you know people with rosacea are more likely to have skin damage, which can lead to poor or impaired skin barrier function? Moisturizing can help protect the skin’s barrier and improve its ability to combat everyday triggers that affect your skin’s barrier function.

  • 3

    Review your skin care routine.

    Your skin is sensitive, and your skin care routine should be, too. Harsh exfoliants and alcohol-based products can worsen blemishes, leading to more redness and breakouts. So, opt for something gentle like oil-free, scent-free and alcohol-free products.

  • 4

    Avoid extreme temperatures.

    Yes, the sun and cold winter winds can cause flare-ups, but temperature triggers aren’t just outdoors. Hot baths, saunas and even being near a fire can leave you flushed. Turn the heat down or limit the time your skin is exposed to extreme temperatures.

  • 5

    Get to know your triggers.

    Everyone is different. Determine what triggers might be causing your rosacea to flare up. Getting to know your triggers will help you tame them in the future.

  • 6

    Stay positive with your course of treatment.

    Remember, skin treatments can take time to improve the symptoms of rosacea, and there isn’t always an immediate impact. Positivity and patience go a long way. But remember, you’re not alone. With the right treatment goals, and guidance from your dermatologist you can see results.

The Different Faces of Rosacea

Rosacea affects people all over the world, from every walk of life. Below are some photographs that display how rosacea can appear on different faces and skin types.

Pictures that display how rosacea can appear on different faces and skin types including differences in age, gender, and race.

Important Safety Information for ORACEA® (doxycycline, USP) 40 mg* Capsules

Indication: ORACEA Capsules are indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients. ORACEA Capsules do not lessen the facial redness caused by rosacea. Adverse Events: In controlled clinical studies, the most commonly reported adverse events (>2%) in patients treated with ORACEA Capsules were nasopharyngitis, sinusitis, diarrhea, hypertension and aspartate aminotransferase increase. Warnings/Precautions: ORACEA Capsules should not be used to treat or prevent infections. ORACEA Capsules should not be taken by patients who have a known hypersensitivity to doxycycline or other tetracyclines. ORACEA Capsules should not be taken during pregnancy, by nursing mothers, or during tooth development (up to the age of 8 years). Although photosensitivity was not observed in clinical trials, ORACEA Capsules patients should minimize or avoid exposure to natural or artificial sunlight. The efficacy of ORACEA Capsules treatment beyond 16 weeks and safety beyond 9 months have not been established. Click here to view the full prescribing information for ORACEA Capsules.

*30 mg immediate release & 10 mg delayed release beads

Important Safety Information for SOOLANTRA® (ivermectin) Cream, 1%

Indication: SOOLANTRA Cream is indicated for the treatment of inflammatory lesions of rosacea. Not for oral, ophthalmic or intravaginal use. Adverse Events: In clinical trials with SOOLANTRA Cream, the most common adverse reactions (incidence ≤ 1 %) included skin burning sensation and skin irritation. Click here to view the full prescribing information for SOOLANTRA Cream.

Important Safety Information for MIRVASO® (brimonidine) topical gel, 0.33%†

Indication: MIRVASO Gel is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older. Adverse Events: In clinical trials, the most common adverse reactions (≥1%) included erythema, flushing, skin burning sensation and contact dermatitis. Warnings/Precautions: MIRVASO Gel should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud’s phenomenon, orthostatic hypotension, thromboangiitis obliterans, scleroderma, or Sjögren’s syndrome. Alpha‐2 adrenergic agents can lower blood pressure. MIRVASO Gel should be used with caution in patients with severe or unstable or uncontrolled cardiovascular disease. Serious adverse reactions following accidental ingestion of MIRVASO Gel by children have been reported. Keep MIRVASO Gel out of reach of children. Not for oral, ophthalmic, or intravaginal use. Click here to view full prescribing information for MIRVASO Gel.

†Each gram of gel contains 5 mg of brimonidine tartrate, equivalent to 3.3 mg of brimonidine free base.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Select a Brand for Prescribing Information:

*30 mg immediate release & 10 mg delayed release beads
†Each gram of gel contains 5 mg of brimonidine tartrate, equivalent to 3.3 mg of brimonidine free base.